CEACAM5 and neoplasm: In contrast to mice that have been given anti-CEA CAR-T cells by injection into the caudal vein, which resulted in a threefold reduction in tumor size, animals receiving anti-CEA CAR-T cells intraperitoneally saw a 37-fold reduction in tumor size.